Latest Articles

Article Type

You have access
Countermeasures against pulmonary threat agents
Jacqui Marzec and Srikanth Nadadur

Journal of Pharmacology and Experimental Therapeutics October 20, 2023, JPET-MR-2023-001822; DOI: https://doi.org/10.1124/jpet.123.001822
You have access
Pramlintide an Adjunct to Insulin Therapy: Challenges and Recent progress in delivery
Sai Pradyuth Kommera, Ankur Kumar, Deepak Chitkara and Anupama Mittal

Journal of Pharmacology and Experimental Therapeutics October 20, 2023, JPET-MR-2023-001679; DOI: https://doi.org/10.1124/jpet.123.001679
You have access
Long-term Neuropsychiatric Developmental Defects after Neonatal Organophosphate Exposure: Mitigation by Synthetic Neurosteroids
Michael Neff and Doodipala Samba Reddy

Journal of Pharmacology and Experimental Therapeutics October 20, 2023, JPET-AR-2023-001763; DOI: https://doi.org/10.1124/jpet.123.001763
Open Access
The Novel GlycoPEGylated FGF21 Analog Pegozafermin Activates Human FGF Receptors and Improves Metabolic and Liver Outcomes in Diabetic Monkeys and Healthy Human Volunteers
Moti Rosenstock, Leo Tseng, Andrew Pierce, Elliot Offman, Chao-Yin Chen, R. Will Charlton, Maya Margalit and Hank Mansbach

Journal of Pharmacology and Experimental Therapeutics November 2023, 387 (2) 204-213; DOI: https://doi.org/10.1124/jpet.123.001618
Open Access
Generation and Characterization of Mirikizumab, a Humanized Monoclonal Antibody Targeting the p19 Subunit of IL-23
Boyd Steere, Catherine Beidler, Andrea Martin, Stu Bright, Kristy Kikly and Robert J. Benschop

Journal of Pharmacology and Experimental Therapeutics November 2023, 387 (2) 180-187; DOI: https://doi.org/10.1124/jpet.122.001512
Open Access
Hydrocodone, Oxycodone, and Morphine Metabolism and Drug–Drug Interactions
Shelby Coates and Philip Lazarus

Journal of Pharmacology and Experimental Therapeutics November 2023, 387 (2) 150-169; DOI: https://doi.org/10.1124/jpet.123.001651
You have access
Correction to “Murine Central Nervous System and Bone Marrow Distribution of the Aurora A Kinase Inhibitor Alisertib: Pharmacokinetics and Exposure at the Sites of Efficacy and Toxicity”
Journal of Pharmacology and Experimental Therapeutics November 2023, 387 (2) 235; DOI: https://doi.org/10.1124/jpet.122.001268err
Open Access
STAR-0215 is a Novel, Long-Acting Monoclonal Antibody Inhibitor of Plasma Kallikrein for the Potential Treatment of Hereditary Angioedema
Vahe Bedian, Nikolaos Biris, Charles Omer, Jou-Ku Chung, James Fuller, Rafif Dagher, Sachin Chandran, Peter Harwin, Tomas Kiselak, Jonathan Violin, Andrew Nichols and Pradeep Bista

Journal of Pharmacology and Experimental Therapeutics November 2023, 387 (2) 214-225; DOI: https://doi.org/10.1124/jpet.123.001740
Open Access
Increasing Enzyme Mannose-6-Phosphate Levels but Not Miglustat Coadministration Enhances the Efficacy of Enzyme Replacement Therapy in Pompe Mice
Allyson Anding, Sofia Kinton, Kaitlyn Baranowski, Alexander Brezzani, Hilde De Busser, Michael R. Dufault, Patrick Finn, Kelly Keefe, Tanya Tetrault, Yi Li, Weiliang Qiu, Katrien Raes, Olivier Vitse, Mindy Zhang, Robin Ziegler, S. Pablo Sardi, Bridge Hunter and Kelly George

Journal of Pharmacology and Experimental Therapeutics November 2023, 387 (2) 188-203; DOI: https://doi.org/10.1124/jpet.123.001593
You have access
Characterization of Selective M₅ Acetylcholine Muscarinic Receptor Modulators on Dopamine Signaling in the Striatum
Vivien Zell, Greetje Teuns, Alexandra Stormy Needham, Sruti Mukherjee, Nathaniel Roscoe, Michelle Le, Lawrence Fourgeaud, Grace Woodruff, Anindya Bhattacharya, Mathieu Marella, Pascal Bonaventure, Wayne C. Drevets and Bartosz Balana

Journal of Pharmacology and Experimental Therapeutics November 2023, 387 (2) 226-234; DOI: https://doi.org/10.1124/jpet.123.001737

Main menu

User menu

Search

Latest Articles

Pages

Navigate

More Information

ASPET's Other Journals